• Did you know that African-Americans need a higher dose of warfarin than other groups? That kind of genetic difference is what makes the FDA's push for diversity in clinical trials so important. Read more >>
MedShadow TV:
Episode 15: The Importance of Diversity in Clinical Trials
Did you know that African-Americans need a higher dose of warfarin than other groups? That kind of genetic difference is what makes the FDA's push for diversity in clinical trials so important.  Read more >> Different ethnicities, genders and ages react differently to medicines. That's why the FDA's push for diversity in clinical trials is so important. Read more 
Need to Know:
Need to Know: Vaping
Yes, there's less nicotine, but vaping has it's own set of dangerous chemicals. And then there are the exploding batteries.... Read more >> Yes, e-cigs have less nicotine, but that doesn't make them totally safe. They have their own chemical issues. And then there are the exploding batteries.... Read more 
MedShadow Blog:
Finding Your Own Path to Health
pecaut By taking responsibility for his health, Picaut eliminated disease and chronic illness. Will it work for you? You'll have to find your own path. Read more 
Feature:
How Mindfulness Meditation Can Help Reduce Meds
A growing number of MDs are looking East as science seems to confirm that How mindfulness meditation can play a role in reducing a need for meds for some patients Read more 
FDA Watch:
What Happens When The FDA Is Addicted to the Drug Industry?
What Happens When The FDA Is Addicted to the Drug Industry? With the FDA receiving the vast majority of its funding to regulate drugs from that very industry, that's a conflict of interest and a major health danger. Read more 
Your Meds: Risks vs Benefits:
It’s a Mistake to Allow Drug Companies to Promote Drugs for Unapproved Uses
Pharmaceutical companies want to persuade doctors to prescribe drugs for off-label uses, a move that is wrong and potentially dangerous for patients. Read more >> Pharmaceutical companies want to persuade doctors to prescribe drugs for off-label uses, a move that is wrong and potentially dangerous for patients. Read more 
Feature:
Limitless? The Difficulty in Tracking Drug Adverse Events in Trials
Limitless?: The Difficulty in Tracking Drug Adverse Events in Trials Pharmaceutical companies don't have to report all adverse events observed in drug trials. If that sounds like trying to hide side effects, you're right. Read more 
MedShadow Blog:
What Actually Works in Fighting a Cold or Flu?
What Actually Works in Fighting a Cold or Flu? Drug store shelves are filled with an overwhelming number of remedies to treat the cold or flu. But which ones actually work? Read more 
FDA Watch:
Time for the FDA to Get Tough on Off-Label Drug Promotion
Time for the FDA to Get Tough on Off-Label Drug Promotion Pharmaceutical companies are getting bolder with pushing off-label drug use to doctors, but will an upcoming meeting embolden the FDA to get tougher? Read more